CAROLINE MCCULLOUGH: Open Payments
NPI 1598482432 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,865 in 77 payments from 27 companies in 2025. Trend: 2023 $0 · 2024 $1,116 · 2025 $1,865
Food & beverage: $1,865
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 13 | $393 |
| Novo Nordisk Inc | 7 | $211 |
| ABBVIE INC. | 9 | $161 |
| Novartis Pharmaceuticals Corporation | 6 | $146 |
| PFIZER INC. | 4 | $91 |
| Astellas Pharma US Inc | 3 | $91 |
| Lilly USA, LLC | 4 | $86 |
| Biogen, Inc. | 3 | $74 |
| Genentech USA, Inc. | 3 | $70 |
| Axsome Therapeutics, Inc. | 2 | $69 |
Products named: Wegovy, Bimzelx, Rystiggo, QULIPTA, Veozah, KESIMPTA, MOUNJARO, NURTEC ODT.
Industry payments across GA — which companies pay providers there.
